BULK PHARMACEUTICAL QUALITY NOW MONITORED BP FDA's BUREAU OF DRUG ANALYSIS IN RECENTLY INITIATED PROGRAM WITH GENERIC DRUG DIV., SEIFE TELLS RAPS MEETING